Teresa Herrador-Alcaide

Feb 10, 2023 | dovepress.com | Ricardo Diaz |Teresa Herrador-Alcaide |Blanca Sánchez-Robles

IntroductionThe COVID-19 shock brought about large social and economic repercussions of various sorts. The pandemic disrupted different sectors and activities. Many effects of the pandemic have been already investigated and discussed. Others, such as the impact on the biopharmaceutical industry, are not well understood yet and deserve further attention. In general, health shocks generate two types of effect on biopharmaceutical firms.